A good example of DGP-associated protein combining both potentials is POMGNT1, whose increased levels correlate well with malignancy, tumor grade, resistance to chemotherapy and low patient survival in human gliomas, and whose intervention, either genetic or pharmacological, could be a good strategy targeting defined cancer types. This evidence concerns the gene POMGNT1 and neoplasm.